Michel Dreano
Oprichter bij Remedys Foundation
Profiel
Michel Dreano is the founder of Sonnet BioTherapeutics CH SA and Remedys Foundation.
Prior to this, he worked as CFO, Director & Chief Business Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019 and as a Manager-Project & Alliance at Serono International SA. Dr. Dreano holds a doctorate degree from L'Université de Bourgogne and Université Paris Diderot-Paris 7.
Actieve functies van Michel Dreano
| Bedrijven | Functie | Begin |
|---|---|---|
| Remedys Foundation | Oprichter | - |
Eerdere bekende functies van Michel Dreano
| Bedrijven | Functie | Einde |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Financieel Directeur/CFO | 26-04-2019 |
| Serono International SA | Corporate Officer/Principal | - |
Sonnet BioTherapeutics CH SA
 Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Oprichter | - |
Opleiding van Michel Dreano
| L'Université de Bourgogne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Université Paris Diderot-Paris 7 | Consumer Services |
| Serono International SA | |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
| Remedys Foundation |
